Martingale Asset Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$216K Sell
2,237
-3,816
-63% -$391K 0.01% 769
2025
Q4
$642K Sell
6,053
-44,828
-88% -$5.2M 0.02% 555
2025
Q3
$6.46M Sell
50,881
-82,848
-62% -$9.86M 0.16% 141
2025
Q2
$16.4M Sell
133,729
-6,910
-5% -$789K 0.4% 92
2025
Q1
$14.2M Sell
140,639
-16,946
-11% -$1.65M 0.36% 99
2024
Q4
$14.6M Sell
157,585
-18,524
-11% -$1.82M 0.35% 105
2024
Q3
$17M Sell
176,109
-1,925
-1% -$173K 0.39% 97
2024
Q2
$15.3M Buy
178,034
+1,004
+0.6% +$84.3K 0.33% 107
2024
Q1
$14.6M Buy
177,030
+18,586
+12% +$1.36M 0.29% 118
2023
Q4
$10.6M Buy
158,444
+152,542
+2,585% +$9.88M 0.22% 130
2023
Q3
$396K Hold
5,902
0.01% 645
2023
Q2
$400K Sell
5,902
-2,912
-33% -$182K 0.01% 653
2023
Q1
$477K Buy
8,814
+2,113
+32% +$123K 0.01% 631
2022
Q4
$401K Buy
+6,701
New +$364K 0.01% 666
2021
Q4
Sell
-3,522
Closed -$212K 839
2021
Q3
$212K Buy
+3,522
New +$222K ﹤0.01% 810
2020
Q4
Sell
-16,247
Closed -$841K 932
2020
Q3
$841K Sell
16,247
-631,960
-97% -$32.4M 0.01% 684
2020
Q2
$31.9M Sell
648,207
-99,150
-13% -$5.35M 0.38% 85
2020
Q1
$38.1M Sell
747,357
-26,464
-3% -$1.53M 0.51% 51
2019
Q4
$42.6M Sell
773,821
-69,823
-8% -$3.79M 0.44% 64
2019
Q3
$42.5M Buy
843,644
+14,009
+2% +$704K 0.43% 69
2019
Q2
$41.8M Sell
829,635
-108,966
-12% -$5.29M 0.44% 71
2019
Q1
$43.6M Buy
938,601
+138,903
+17% +$7.04M 0.47% 62
2018
Q4
$39.3M Buy
799,698
+30,782
+4% +$1.75M 0.52% 47
2018
Q3
$47.7M Buy
768,916
+551,815
+254% +$33.6M 0.56% 43
2018
Q2
$11.7M Buy
217,101
+71,489
+49% +$3.57M 0.14% 175
2018
Q1
$6.62M Sell
145,612
-10,570
-7% -$453K 0.09% 226
2017
Q4
$6.14M Sell
156,182
-22,235
-12% -$846K 0.08% 235
2017
Q3
$6.58M Buy
178,417
+1,396
+0.8% +$49.7K 0.09% 233
2017
Q2
$6.82M Buy
177,021
+18
+0% +$659 0.1% 214
2017
Q1
$6.03M Buy
177,003
+11,190
+7% +$367K 0.09% 242
2016
Q4
$5.44M Buy
165,813
+24,393
+17% +$791K 0.08% 295
2016
Q3
$4.57M Buy
141,420
+126,203
+829% +$4.09M 0.07% 299
2016
Q2
$470K Hold
15,217
0.01% 681
2016
Q1
$456K Sell
15,217
-4,274
-22% -$118K 0.01% 669
2015
Q4
$540K Sell
19,491
-4
-0% -$114 0.01% 640
2015
Q3
$596K Sell
19,495
-10,562
-35% -$368K 0.01% 614
2015
Q2
$1.1M Sell
30,057
-13,146
-30% -$469K 0.03% 491
2015
Q1
$1.52M Sell
43,203
-33,278
-44% -$1.14M 0.04% 381
2014
Q4
$2.34M Buy
76,481
+3,727
+5% +$116K 0.06% 300
2014
Q3
$2.14M Buy
72,754
+33,394
+85% +$1.02M 0.07% 289
2014
Q2
$1.12M Buy
39,360
+19,611
+99% +$547K 0.04% 483
2014
Q1
$565K Buy
19,749
+2,138
+12% +$55.7K 0.02% 655
2013
Q4
$467K Sell
17,611
-6
-0% -$167 0.02% 791
2013
Q3
$484K Buy
+17,617
New +$452K 0.02% 758

Other funds holding EHC

Martingale Asset Management's EHC Position: Q1 2026 in Review

Martingale Asset Management reduced its Encompass Health (EHC) stake by 63% in Q1 2026, selling an estimated $391K and leaving 2,237 shares worth $216K. The position accounts for 0.01% of the portfolio, ranked #769.

Martingale Asset Management first reported a position in EHC in Q3 2013 and has held it in 44 quarters since. The position peaked at $47.7M in Q3 2018. 578 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Martingale Asset Management held 2,237 shares of Encompass Health worth $216K as of Q1 2026.
  • Martingale Asset Management sold 3,816 Encompass Health shares in Q1 2026, an estimated $391K.
  • Encompass Health made up 0.01% of Martingale Asset Management's portfolio in Q1 2026, its #769 holding.
  • Martingale Asset Management first reported a position in Encompass Health in Q3 2013 and has held it in 44 quarters since.
  • Martingale Asset Management's Encompass Health position peaked at $47.7M in Q3 2018.
  • 578 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Martingale Asset Management's 13F filing for Q1 2026, filed 13 May 2026.